Page 1124 - Williams Hematology ( PDFDrive )

1098 Part VIII: Monocytes and Macrophages Chapter 70: Monocytosis and Monocytopenia 1099

18. Haferlach T, Schoch C, Schnittger S, et al: Distinct genetic patterns can be identified in 55. Buchan GS, Palmer DG, Gibbins BL: The response of human peripheral blood mono-
acute monoblastic leukaemia (FAB AML M5a and M5b): A study of 124 patients. Br J nuclear phagocytes to rheumatoid arthritis. J Leukoc Biol 37:221, 1985.
Haematol 118:426, 2002. 56. Budman DR, Steinberg AD: Hematologic aspects of systemic lupus erythematosus.
19. Villeneuve P, Kim DT, Xu W, et al: The morphological subcategories of acute monocytic Current concepts. Ann Intern Med 86:220, 1977.
leukemia (M5a and M5b) share similar immunophenotypic and cytogenetic features 57. Goodwin JS, DeHaratius R, Israel H, et al: Suppressor cell function in sarcoidosis. Ann
and clinical outcomes. Leuk Res 32:269, 2008. Intern Med 90:169, 1979.
20. Sun X, Zhang W, Ramdas L, et al: Comparative analysis of genes regulated in acute mye- 58. Daniele RP, Dauber JH, Rossman MD: Immunologic abnormalities in sarcoidosis. Ann
lomonocytic leukemia with and without inv(16)(p13q22) using microarray techniques, Intern Med 92:406, 1980.
real-time PCR, immunohistochemistry, and flow cytometry immunophenotyping. 59. Stobie W, England NJ, McMenemy WH: The interpretation of haemograms in pulmo-
Mod Pathol 20:811, 2007. nary tuberculosis. Am Rev Tuberc 46:1, 1942.
21. Laurencet FM, Chapius B, Roux-Lombard P, et al: Malignant histiocytosis in the leu- 60. Flinn JW: A study of the differential blood count in 1000 cases of active pulmonary
kaemic stage: A new entity (M5c-AML) in the FAB classification? Leukemia 8:502, 1994. tuberculosis. Ann Intern Med 2:622, 1929.
22. Ferran M, Gallardo F, Ferrer AM, et al: Acute myeloid dendritic cell leukaemia with 61. Singh KJ, Ahluwalia G, Sharma SK, et al: Significance of haematological reactions in
specific cutaneous involvement: A diagnostic challenge. Br J Dermatol 158:1129, 2008. patients with tuberculosis. J Assoc Physicians India 49:788, 2001.
23. Santiago-Schwartz F, Coppock DL, Hindenberg AA, Kern J: Identification of a malig- 62. Smith MB, Schnadig VJ, Boyars MC, Woods GL: Clinical and pathological features of
nant counterpart of the monocytic-dendritic cell progenitor in an acute myeloid leuke- Mycobacterium fortuitum infections: An emerging pathogen in patients with AIDS.
mia. Blood 84:3054, 1994. Am J Clin Pathol 116:225, 2001.
24. Lichtman MA, Segel GB: Uncommon phenotypes of acute myelogenous leukemia: 63. Daland GA, Gottlieb L, Wallerstein RO, et al: Hematologic observations in bacterial
Basophilic, mast cell, eosinophilic, and myeloid dendritic cell subtypes: A review. Blood endocarditis. J Lab Clin Med 48:827, 1956.
Cells Mol Dis 35:370, 2005. 64. Myhre EB, Braconier JH, Sjögren U: Automated cytochemical differential leukocyte
25. Frew ME, Donaldson K: Monocyte analysis in chronic myelomonocytic leukaemia. Br count in patients hospitalized with acute bacterial infections. Scand J Infect Dis 17:201,
J Biomed Sci 54:244, 1997. 1985.
26. Onida F, Kantarjian HM, Smith TL, et al: Prognostic scoring factors and scoring sys- 65. Hill RW, Bayrd ED: Phagocytic reticuloendothelial cells in subacute bacterial endocar-
tems in chronic myelomonocytic leukemia: A retrospective analysis of 213 patients. ditis with negative cultures. Ann Intern Med 52:310, 1960.
Blood 99:840, 2002. 66. Tsolia M, Drakonaki S, Messaritaki A, et al: Clinical features, complications and treat-
27. Xu Y, McKenna RW, Karandikar NJ, et al: Flow cytometric analysis of monocytes as a ment outcome of childhood brucellosis in central Greece. J Infect 44:257, 2002.
tool for distinguishing chronic myelomonocytic leukemia from reactive monocytosis. 67. Khan E, Siddiqui J, Shakoor S, et al: Dengue outbreak in Karachi, Pakistan, 2006: Expe-
Am J Clin Pathol 124:799, 2005. rience at a tertiary care center. Trans R Soc Trop Med Hyg 101:1114, 2007.
28. Kratz CP, Niemeyer CM: Juvenile myelomonocytic leukemia. Hematology 1:100, 2005. 68. Hickling RA: The monocytes in pneumonia: A clinical and hematologic study. Arch
29. Ohsaka A, Shiina S, Kobayashi M, et al: Philadelphia chromosome-positive chronic Intern Med 40:594, 1927.
myeloid leukemia expressing p190(BCR-ABL). Intern Med 41:1092, 2002. 69. Rosahn PD, Pearce L: The blood cytology in untreated and treated syphilis. Am J Med
30. Hur M, Song HM, Kang SH, et al: Lymphoid predominance and the absence of Sci 187:88, 1934.
basophilia and splenomegaly are frequent in m-bcr-positive chronic myelogenous leu- 70. Karyalcin G, Khanijou A, Kim KY, et al: Monocytosis in congenital syphilis. Am J Dis
kemia. Ann Hematol 81:219, 2002. Child 131:782, 1977.
31. Wright D, Dale DC, Fauci AS, Wolff SM: Human cyclic neutropenia: Clinical review 71. Klemola E: Cytomegalovirus infection in previously healthy adults. Ann Intern Med
and long-term follow-up of patients. Medicine (Baltimore) 60:1, 1981. 79:267, 1973.
32. Zuelzer WW, Bajoghli M: Chronic granulocytopenia in childhood. Blood 23:359, 1964. 72. Tsukahara T, Yogushi A, Horiuchi Y: Significance of monocytosis in varicella herpes
33. Cutting HO, Lang JE: Familial benign chronic neutropenia. Ann Intern Med 61:876, zoster. J Dermatol 19:94, 1992.
1964. 73. McClain MT, Park LP, Nicholson B, et al: Longitudinal analysis of leukocyte differen-
34. Krill CE, Mauer AM: Congenital agranulocytosis. J Pediatr 68:361, 1966. tials in peripheral blood of patients with acute respiratory viral infections. J Clin Virol
35. Lang JE, Cutting HO: Infantile genetic agranulocytosis. Pediatrics 35:596, 1965. 58:689, 2013.
36. Spaet TH, Dameshek W: Chronic hypoplastic neutropenia. Am J Med 13:35, 1952. 74. McKeever UM, O’Mahoney C, Lawlor E, et al: Monocytosis: A feature of alcoholic liver
37. Robinson RL, Burk MS, Raman S: Fever, delirium, autonomic instability, and monocy- disease. Lancet 2:1492, 1983.
tosis associated with olanzapine. J Postgrad Med 49:96, 2003. 75. Mees AS, Berney J, Jewell DP: Monocytes in inflammatory bowel disease: Absolute
38. Graf M, Tarlov A: Agranulocytosis with monohistiocytosis associated with ampicillin monocyte counts. J Clin Pathol 33:917, 1980.
therapy. Ann Intern Med 69:91, 1968. 76. Barrett O Jr: Monocytosis in malignant disease. Ann Intern Med 73:991, 1970.
39. Thöne J, Kessler E: Monocytosis subsequent to ziprasidone treatment: A possible side 77. Wood GW, Neff JE, Stephens R: Relationship between monocytosis and T-lymphocyte
effect. Prim Care Companion J Clin Psychiatry 9:465, 2007. function in human cancer. J Natl Cancer Inst 63:587, 1979.
40. Reznikoff P: The etiologic importance of fatigue and the prognostic significance of 78. Melichar B, Touskova M, Vesely P: Effect of irinotecan on the phenotype of peripheral
monocytosis in neutropenia (agranulocytosis). Am J Clin Pathol 6:205, 1936. blood leukocyte populations in patients with metastatic colorectal cancer. Hepatogas-
41. Rosenthal N, Abel HA: The significance of the monocytes in agranulocytosis (leuko- troenterology 49:967, 2002.
penic infectious agranulocytosis). Am J Clin Pathol 6:205, 1936. 79. Ruka W, Rutkowski p, Kaminska J, et al: Alterations of routine blood tests in adult
42. Pretty HM, Gosselin G, Colprian G, Long LA: Agranulocytosis: A report of 30 cases. patients with soft tissue sarcomas: Relationships to cytokine serum levels and prognos-
Can Med Assoc J 93:1058, 1965. tic significance. Ann Oncol 12:1423, 2001.
43. Rosenberg SA, Diamond HD, Jaslowitz B, Craver LF: Lymphosarcoma: A review of 80. Schmitz LL, McClure JS, Litz CE, et al: Morphologic and quantitative changes in blood
1269 cases. Medicine (Baltimore) 40:31, 1961. and marrow cells following growth factor therapy. Am J Clin Pathol 101:67, 1994.
44. Ultmann JE: Clinical features and diagnosis of Hodgkin’s disease. Cancer 9:297, 1966. 81. Chernoff AE, Granowitz EV, Shapiro L, et al: A randomized controlled trial of IL-10 in
45. Kaplan HS: Hodgkin’s Disease, 2nd ed, Table 4.1, pp 127–128. Harvard University Press, humans. J Immunol 154:5492, 1995.
Cambridge, MA, 1980. 82. Ranaghan L, Drake M, Humphreys MW, Morris TC: Leukaemoid monocytosis in M4
46. Sewell RL: Lymphocyte abnormalities in myeloma. Br J Haematol 36:545, 1977. AML following chemotherapy: G-CSF. Clin Lab Haematol 20:49, 1998.
47. Blom J, Nielsen H, Larsen SO, et al: A study of certain functional parameters of mono- 83. Liu CZ, Persad R, Inghirami G, et al: Transient atypical monocytosis mimic acute mye-
cytes from patients with multiple myeloma: Comparison with monocytes from healthy lomonocytic leukemia in post-chemotherapy patients receiving G-CSF: Report of two
individuals. Scand J Haematol 33:425, 1984. cases. Clin Lab Haematol 26:359, 2004.
48. Nakajima H, Mori S, Takeuchi T, et al: Monocytosis and high serum macrophage col- 84. Weiner LM, Li W, Holmes M, et al: Phase I trial of recombinant macrophage colony-
ony-stimulating factor in Waldenström’s macroglobulinemia. Blood 86:2863, 1995. stimulating factor and recombinant gamma-interferon: Toxicity, monocytosis, and
49. Tokioka T, Shimamoto Y, Motoyoshi K, Yamaguchi M: Clinical significance of mono- clinical effects. Cancer Res 54:4084, 1994.
cytosis and human monocytic colony stimulating factor in patients with adult T-Cell 85. Minasian LM, Yao TJ, Steffens TA, et al: A phase I study of anti-GD3 ganglioside mono-
leukaemia/lymphoma. Haematologia (Budap) 26:1, 1994. clonal antibody R24 and recombinant human macrophage-colony stimulating factor in
50. Bari A, Tadmor T, Sacchi S, et al: Monocytosis has adverse prognostic significance and patients with metastatic melanoma. Cancer 75:2251, 1995.
impacts survival in patients with T-cell lymphomas. Leuk Res 37:619, 2013. 86. Marshall E, Howell AH, Powles R, et al: Clinical effects of human macrophage inflam-
51. Mazumdar R, Evans P, Culpin R, et al: The automated monocyte count is independently matory protein-1 alpha MIP-1 alpha (LD78) administration in humans. Eur J Cancer
predictive of overall survival from diagnosis in chronic lymphocytic leukaemia and of 34:1023, 1998.
survival following first-line chemotherapy. Leuk Res 37:614, 2013. 87. Meisel SR, Panzner H, Schecter M, et al: Peripheral monocytosis following myocardial
52. Choi TS, Doh KS, Kim SH, et al: Clinicopathological and genotypic aspects of anticon- infarction. Cardiology 90:52, 1998.
vulsant-induced pseudolymphoma syndrome. Br J Dermatol 148:730, 2003. 88. Maekawa Y, Anzai T, Yoshikawa T, et al: Prognostic significance of peripheral mono-
53. Durig M, Landmann RMA, Harder F: Lymphocyte subsets in human peripheral blood cytosis after reperfusion acute myocardial infarction: Possible role for left ventricular
after splenectomy and autotransplantation of splenic tissue. J Lab Clin Med 104:110, remodeling. J Am Coll Cardiol 16:241, 2002.
1984. 89. Gibson WJ, Gibson CM: The association of impaired myocardial perfusion and mono-
54. Lanng Nielson J, Romer FK, Ellegaard J: Serum angiotensin-converting enzyme and cytosis with late recovery of left ventricular function following primary percutaneous
blood monocytes in splenectomized individuals. Acta Haematol 67:132, 1982. coronary intervention. Eur Heart J 27:2487, 2006.

Kaushansky_chapter 70_p1095-1100.indd 1099 9/18/15 9:49 AM